Library / Laws / 117th Congress / House Bills / H.R. 7473
H.R. 7473
To prohibit pharmaceutical manufacturers from interfering with therapeutically equivalent or interchangeable substitution decisions by health care providers to limit competition from a generic drug or biosimilar biological product, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2022-04-07 | 8.4K | ⠃⠗⠋ |